XML 125 R104.htm IDEA: XBRL DOCUMENT v3.25.3
Commitments and Contingencies (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 12, 2025
USD ($)
May 26, 2025
USD ($)
Jan. 17, 2025
USD ($)
Nov. 13, 2024
USD ($)
shares
Jun. 05, 2023
USD ($)
Jan. 30, 2023
patent
Oct. 13, 2020
patent
Nov. 04, 2015
USD ($)
Oct. 31, 2024
USD ($)
Feb. 28, 2023
patent
Sep. 27, 2025
USD ($)
distributor
executiveOfficer
Sep. 28, 2024
distributor
Sep. 27, 2025
USD ($)
executiveOfficer
distributor
shares
Sep. 28, 2024
distributor
shares
Dec. 28, 2024
USD ($)
Oct. 24, 2024
USD ($)
Oct. 20, 2022
complaint
Contingencies And Commitments [Line Items]                                  
Severance plan participation agreements | executiveOfficer                     3   3        
Required notice of resignation                         6 months        
License fee                     $ 2,500,000   $ 2,500,000        
Change in control                     15,000,000   15,000,000     $ 15,000,000  
Additional change in control                               $ 2,000,000  
Remaining commitment                     252,600,000   252,600,000        
Other commitment                     4,600,000   4,600,000        
Loss contingency, success fee, payments $ 2,800,000                                
Success fees outstanding                     0   0        
Cash and cash equivalents                     312,300,000   312,300,000   $ 123,600,000    
Bank balance covered by federal deposit insurance corporation limit                     $ 4,200,000   $ 4,200,000        
Sales                                  
Contingencies And Commitments [Line Items]                                  
Distributors | distributor                     1 1 1 1      
GPO Members | Revenue Benchmark | Customer Concentration Risk                                  
Contingencies And Commitments [Line Items]                                  
Concentration risk, percentage                     58.20% 57.30% 58.70% 57.90%      
Just in Time Distributor One | Revenue Benchmark | Customer Concentration Risk                                  
Contingencies And Commitments [Line Items]                                  
Concentration risk, percentage                     18.40% 23.80% 18.80% 20.30%      
Customer One | Accounts Receivable | Customer Concentration Risk                                  
Contingencies And Commitments [Line Items]                                  
Percentage of accounts receivable balance                     22.50%   22.50%   12.20%    
Customer Two | Accounts Receivable | Customer Concentration Risk                                  
Contingencies And Commitments [Line Items]                                  
Percentage of accounts receivable balance                             11.90%    
Ms Catherine Szyman                                  
Contingencies And Commitments [Line Items]                                  
Annual base salary     $ 1,000,000                            
Annual target long-term incentive award     $ 7,000,000                            
Retirement policy attainment period     60 years                            
Continuous employment period     5 years                            
Ms Catherine Szyman | Minimum                                  
Contingencies And Commitments [Line Items]                                  
Base salary percentage     100.00%                            
Ms Catherine Szyman | Maximum                                  
Contingencies And Commitments [Line Items]                                  
Base salary percentage     200.00%                            
Restricted Stock Units (RSUs)                                  
Contingencies And Commitments [Line Items]                                  
Share-based compensation arrangement, grants in period (in shares) | shares                         300,000        
Brennan Agreement                                  
Contingencies And Commitments [Line Items]                                  
Annual base salary       $ 1,042,000                          
Discretionary bonus of target amount       621,250                          
Discretionary bonus amount       $ 1,087,190                          
Brennan Agreement | Restricted Stock Units (RSUs)                                  
Contingencies And Commitments [Line Items]                                  
Share-based compensation arrangement, grants in period (in shares) | shares       8,916                          
Masimo Vs. Apple Inc                                  
Contingencies And Commitments [Line Items]                                  
Number of patents found infringed | patent           1       2              
Masimo Vs. Apple Inc | Pending Litigation                                  
Contingencies And Commitments [Line Items]                                  
Asserted patents found valid | patent             3                    
Asserted patents found invalid | patent             9                    
Apple, Inc. Patent Infringement | Pending Litigation                                  
Contingencies And Commitments [Line Items]                                  
Number of complaints | complaint                                 2
Loss contingency, damages awarded, value                 $ 250                
Masimo V.S. Willow Laboratories | Pending Litigation                                  
Contingencies And Commitments [Line Items]                                  
Loss contingency, damages sought, value   $ 2,750,000                              
Chief Executive Officer                                  
Contingencies And Commitments [Line Items]                                  
Severance payment period               3 years                  
Equity awards               $ 2,700,000                  
Cash payment               $ 35,000,000                  
Qualifying termination         $ 479,700,000                        
Chief Executive Officer | Restricted Stock Units (RSUs)                                  
Contingencies And Commitments [Line Items]                                  
Share-based compensation arrangement, grants in period (in shares) | shares                         2,700,000 2,700,000